234 related articles for article (PubMed ID: 33741764)
61. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C
Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414
[TBL] [Abstract][Full Text] [Related]
62. TTF-1-positive Metastatic Endometrioid Carcinoma: A Case Report and Review of Literature of a Potential Diagnostic Pitfall.
Casteillo F; Fournel P; Da Cruz V; Karpathiou G; Boutet C; Jacquin JP; Tissot C; Meyer-Bisch V; Péoc'h M; Forest F
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):e6-e9. PubMed ID: 28777147
[TBL] [Abstract][Full Text] [Related]
63. Endometrial endometrioid carcinomas associated with Ewing sarcoma/peripheral primitive neuroectodermal tumor.
Sinkre P; Albores-Saavedra J; Miller DS; Copeland LJ; Hameed A
Int J Gynecol Pathol; 2000 Apr; 19(2):127-32. PubMed ID: 10782408
[TBL] [Abstract][Full Text] [Related]
64. Endometrial carcinoma and non-Hodgkin's lymphoma involving the female genital tract: a report of three cases.
Vang R; Silva EG; Medeiros LJ; Deavers M
Int J Gynecol Pathol; 2000 Apr; 19(2):133-8. PubMed ID: 10782409
[TBL] [Abstract][Full Text] [Related]
65. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
[TBL] [Abstract][Full Text] [Related]
66. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
67. An extremely rare presentation of relapse in endometrioid endometrial adenocarcinoma: isolated metastases to the tibia and humerus. Case report and review of the literature.
Gottwald L; Dukowicz A; Misiewicz B; Pasz-Walczak G; Cialkowska-Rysz A
Eur J Gynaecol Oncol; 2011; 32(5):547-50. PubMed ID: 22053672
[TBL] [Abstract][Full Text] [Related]
68. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
Alkushi A; Köbel M; Kalloger SE; Gilks CB
Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
[TBL] [Abstract][Full Text] [Related]
69. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
Tambouret R; Clement PB; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
[TBL] [Abstract][Full Text] [Related]
70. Undifferentiated endometrial carcinoma: a diagnosis frequently overlooked.
Al-Loh S; Al-Hussaini M
Arch Pathol Lab Med; 2013 Mar; 137(3):438-42. PubMed ID: 23451754
[TBL] [Abstract][Full Text] [Related]
71. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
Younes SF; Aiad H; Kandil M; El Kalashy FS
Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
[TBL] [Abstract][Full Text] [Related]
72. Uterine collision tumor of endometrial stromal sarcoma and endometrioid adenocarcinoma: A rare case report and review of literature.
Sharma S; Vasdev N; Pandey D
Indian J Pathol Microbiol; 2021; 64(4):802-805. PubMed ID: 34673609
[TBL] [Abstract][Full Text] [Related]
73. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
74. Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.
Mulligan AM; Plotkin A; Rouzbahman M; Soslow RA; Gilks CB; Clarke BA
Am J Surg Pathol; 2010 Aug; 34(8):1132-8. PubMed ID: 20588176
[TBL] [Abstract][Full Text] [Related]
75. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.
Allo G; Bernardini MQ; Wu RC; Shih IeM; Kalloger S; Pollett A; Gilks CB; Clarke BA
Mod Pathol; 2014 Feb; 27(2):255-61. PubMed ID: 23887303
[TBL] [Abstract][Full Text] [Related]
76. Undifferentiated carcinoma of the endometrium.
Altrabulsi B; Malpica A; Deavers MT; Bodurka DC; Broaddus R; Silva EG
Am J Surg Pathol; 2005 Oct; 29(10):1316-21. PubMed ID: 16160474
[TBL] [Abstract][Full Text] [Related]
77. Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas.
Zhang K; Liu Y; Liu X; Du J; Wang Y; Yang J; Li Y; Liu C
Pathology; 2021 Feb; 53(2):179-186. PubMed ID: 33070954
[TBL] [Abstract][Full Text] [Related]
78. Endometrial stromal sarcoma with coexistent endometrioid adenocarcinoma in a woman with previous breast cancer: a preliminary case report.
Celik H; Kokcu A; Yildiz L
Eur J Gynaecol Oncol; 2013; 34(5):493-5. PubMed ID: 24475593
[TBL] [Abstract][Full Text] [Related]
79. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis.
Asaka S; Liu Y; Yu ZC; Rahmanto YS; Ono M; Asaka R; Miyamoto T; Yen TT; Ayhan A; Wang TL; Shih IM
Mod Pathol; 2023 Feb; 36(2):100045. PubMed ID: 36853791
[TBL] [Abstract][Full Text] [Related]
80. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
Taylor J; McCluggage WG
Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
